Fatostatin

CAS No. 298197-04-3

Fatostatin ( —— )

Catalog No. M18384 CAS No. 298197-04-3

Fatostatin ia an inhibitor of sterol regulatory element binding protein (SREBP). It impairs the activation of SREBP-1 and SREBP-2.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 In Stock
10MG 60 In Stock
25MG 109 In Stock
50MG 182 In Stock
100MG 309 In Stock
500MG 746 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fatostatin
  • Note
    Research use only, not for human use.
  • Brief Description
    Fatostatin ia an inhibitor of sterol regulatory element binding protein (SREBP). It impairs the activation of SREBP-1 and SREBP-2.
  • Description
    Fatostatin ia an inhibitor of sterol regulatory element binding protein (SREBP). It impairs the activation of SREBP-1 and SREBP-2.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    SREBPs
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    298197-04-3
  • Formula Weight
    375.33
  • Molecular Formula
    C18H18N2S·HBr
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    Cc1ccc(cc1)c1csc(c2cc(CCC)ncc2)n1.Br
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kamisuki S, et al. A small molecule that blocks fat synthesis by inhibiting the activation of SREBP.Chem Biol. 2009, 16(8):882-92.
molnova catalog
related products
  • APD-371

    APD-371 (APD371, Olorinab)is a potent, selective and orally available CB2 agonist with EC50 of 6.2 nM; displays no activity against CB1 receptors (EC50>10 uM).

  • Tetrahydromagnolol

    Tetrahydromagnolol can activate cannabinoid (CB) receptors.

  • Hemopressin (human, ...

    Bioactive endogenous peptide substrate for endopeptidase 24.15 (ep24.15), neurolysin (ep24.16) and ACE. Ki values are 27.76, 3.43 and 1.87 μM respectively. Potent hypotensive in vivo. Also acts as a selective CB1 receptor inverse agonist. Displays antinociceptive activity in vivo.